Prognostic value of tumor-to-parenchymal contrast enhancement ratio on portal venous-phase CT in pancreatic neuroendocrine neoplasms.
Hyo Jung ParkHyoung Jung KimJung Hoon KimSo Yeon KimSang Hyun ChoiJae Ho ByunSong Cheol KimHee Sang HwangSeung-Mo HongPublished in: European radiology (2022)
• In pancreatic neuroendocrine neoplasms, the tumor-to-parenchymal enhancement ratio on portal venous-phase CT (CER on PVP) showed acceptable predictive performance of postoperative outcomes. • CER on PVP showed superior predictive performance of postoperative survival over the current WHO classification and AJCC staging system.